General Information of the Compound
| Compound ID |
CP0852593
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
5-([1,1'-Biphenyl]-4-yl)-3-(4-(4-(1,1,1,3,3,3-hexafluoro-2-hydroxypropan-2-yl)-2,6-di-n-propylphenoxy)butyl)-5-methylimidazolidine-2,4-dione
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C35H38F6N2O4
|
||||||||||||||||||
| Molecular Weight |
664.687
|
||||||||||||||||||
| Canonical SMILES |
CCCc1cc(C(O)(C(F)(F)F)C(F)(F)F)cc(CCC)c1OCCCCN1C(=O)NC(C)(c2ccc(-c3ccccc3)cc2)C1=O
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C35H38F6N2O4/c1-4-11-25-21-28(33(46,34(36,37)38)35(39,40)41)22-26(12-5-2)29(25)47-20-10-9-19-43-30(44)32(3,42-31(43)45)27-17-15-24(16-18-27)23-13-7-6-8-14-23/h6-8,13-18,21-22,46H,4-5,9-12,19-20H2,1-3H3,(H,42,45)
Show/Hide
|
||||||||||||||||||
| InChIKey |
RCKQCCMFAJVUEW-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01555, Oxysterols receptor LXR-alpha
Protein ID: PT01887, Oxysterols receptor LXR-beta